Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
HKPDCellyan Biotechnology Co., Ltd
| Figure | HKPDCellyan Biotechnology Co., LtdFY2025 · Mar |
|---|---|
| Revenue | $20.31M |
| Revenue, yoy | +21.7% |
| Net income | $27.06K |
| Net income, yoy | −102.0% |
| Net margin | -0.1% |
| Free cash flow | $499.30K |
| FCF margin | 2.5% |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2023–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed